This has been demonstrated by treating human breast cancer cells with tetrandrine [195] or the known autophagy inducer Rottlerin, which promotes the cell death of breast cancer stem cells by mediating the suppression of Akt and mTOR signaling, and the up-regulation of phospho-AMPK [196]. This evidence concerns the gene AKT1 and breast carcinoma.